Medicine

Projects

Projects per year 1975 1989 2002 2005 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2025

• 25 Not started
• 128 Active
• 802 Finished

Projects per year

Search results

• LEVEL OF ACE INHIBITION IN HEART FAILURE

  Jorde, U. P.

  9/30/99 → 8/31/04

  Project: Research project

  • Peptidyl-Dipeptidase A 100%
  • Angiotensin-Converting Enzyme Inhibitors 77%
  • Heart Failure 47%
  • Mentors 32%
  • Cardiology 25%

• AIDS MALIGNANCY CONSORTIUM

  Sparano, J. A. & Rose, S. A.

  9/20/99 → 5/31/06

  Project: Research project

  • Lebanon 100%
  • Acquired Immunodeficiency Syndrome 60%
  • Clinical Trials 57%
  • HIV 50%
  • Neoplasms 28%

• AIDS MALIGNANCY CONSORTIUM

  Sparano, J. A.

  9/20/99 → 5/31/06

  Project: Research project

  • Lebanon 100%
  • Acquired Immunodeficiency Syndrome 60%
  • Clinical Trials 57%
  • HIV 50%
  • Neoplasms 28%

• CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE

  Wang, D. Q. H. & Rose, S. A.

  9/1/99 → 8/31/10

  Project: Research project

  • cholelithiasis 100%
  • cholesterol 80%
  • cholesterol homeostasis 22%
  • mice 16%
  • chylomicrons 12%

• CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.

  Wang, D. Q. H.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/1/99 → 8/31/10

  Project: Research project

  • cholesterol homeostasis 100%
  • cholelithiasis 60%
  • Gallstones 50%
  • cholesterol 48%
  • Cholesterol 46%

• CARRIER MEDIATED ANTIFOLATE TRANSPORT AND RESISTANCE

  Goldman, I. D., Goldman, I. D., Rose, S. A. & Rose, S. A.

  9/1/99 → 7/31/19

  Project: Research project

  • Folic Acid Antagonists 100%
  • Anions 39%
  • Folic Acid 35%
  • Mutation 33%
  • Thymidylate Synthase 32%

• VEGF INDUCED SIGNAL TRANSDUCTION

  Sibinga, N. E. S., Terman, B., Rose, S. A. & Rose, S. A.

  8/16/99 → 4/30/10

  Project: Research project

  • Vascular Endothelial Growth Factor A 100%
  • Signal Transduction 90%
  • Neoplasms 87%
  • Nutrients 65%
  • Endothelial Cells 57%

• VEGF Induced Signal Transduction

  Terman, B. & Sibinga, N. E. S.

  National Cancer Institute

  8/16/99 → 4/30/10

  Project: Research project

  • Vascular Endothelial Growth Factor A 100%
  • Signal Transduction 74%
  • Cell Proliferation 37%
  • Reactive Oxygen Species 22%
  • Non-Receptor Type 6 Protein Tyrosine Phosphatase 22%

• GENE INTERACTIONS IN COLON CANCER

  Augenlicht, L. H.

  4/6/99 → 1/31/05

  Project: Research project

  • Thymidylate Synthase 100%
  • myc Genes 19%
  • Messenger RNA 18%
  • Fluorouracil 15%
  • Colonic Neoplasms 14%

• GENE INTERACTIONS IN COLON CANCER

  Augenlicht, L. H.

  National Cancer Institute

  4/6/99 → 1/31/05

  Project: Research project

  • Thymidylate Synthase 100%
  • Colonic Neoplasms 59%
  • Genes 25%
  • myc Genes 19%
  • Messenger RNA 18%

• CASPASES AND MYOCYTE APOPTOSIS IN HEART FAILURE

  Kitsis, R. N. & Rose, S. A.

  9/30/98 → 6/30/08

  Project: Research project

  • Caspases 100%
  • Apoptosis 98%
  • Cardiac Myocytes 80%
  • Heart Failure 72%
  • Muscle Cells 56%

• ARC, a Master Repressor of Apoptosis in Striated Muscle

  Kitsis, R. N.

  National Heart, Lung, and Blood Institute

  9/30/98 → 6/30/08

  Project: Research project

  • AIDS-Related Complex 100%
  • Apoptosis 85%
  • Striated Muscle 73%
  • Caspases 72%
  • Cardiac Myocytes 72%

• GENETIC ENGINEERING OF BETA CELLS FOR TRANSPLANTATION

  Brownlee, M. A.

  9/30/98 → 9/29/01

  Project: Research project

  • Genetic Engineering 100%
  • Internal Ribosome Entry Sites 57%
  • Down-Regulation 55%
  • Cre recombinase 54%
  • bcl-2 Genes 52%

• TIME &SCBA TANK USE ON INJURY PREVENTION/FIRE FIGHTERS

  Prezant, D. J. & Prezant, D. J.

  9/30/98 → 9/29/02

  Project: Research project

  • heat 74%
  • time 59%
  • miner 41%
  • occupation 27%
  • worker 21%

• CARDIAC MYOCYTE APOPTOSIS--MECHANISM AND SIGNIFICANCE

  Kitsis, R. N., Rose, S. A. & Rose, S. A.

  8/1/98 → 3/31/15

  Project: Research project

  • Apoptosis 100%
  • Muscle Cells 65%
  • Caspases 62%
  • Cardiac Myocytes 57%
  • Myocardial Ischemia 45%

• Cardiac Myocyte Apoptosis: Mechanism and Significance

  Kitsis, R. N.

  National Heart, Lung, and Blood Institute

  8/1/98 → 3/31/15

  Project: Research project

  • Cardiac Myocytes 100%
  • AIDS-Related Complex 98%
  • Apoptosis 65%
  • Reperfusion Injury 18%
  • Reperfusion 16%

• MYCOBACTERIOPHANGE INTERACTION WITH M TUBERCULOSIS

  Riska, P. F.

  7/15/98 → 6/30/04

  Project: Research project

  • Mycobacterium 100%
  • Tuberculosis 76%
  • Bacteriophages 68%
  • Molecular Biology 56%
  • Fireflies 39%

• MELANOGENESIS IN CRYPTOCOCCUS NEOFORMANS

  Nosanchuk, J. D.

  7/1/98 → 12/31/03

  Project: Research project

  • melanin 100%
  • melanogenesis 57%
  • Cryptococcus neoformans 44%
  • monoclonal antibodies 31%
  • peptides 19%

• LIPID INTERACTIONS IN INSULIN SECRETION/SENSITIVITY

  Stein, D. T.

  6/15/98 → 4/30/03

  Project: Research project

  • Hyperinsulinism 100%
  • Insulin Resistance 99%
  • Muscles 45%
  • Triglycerides 36%
  • Type 2 Diabetes Mellitus 34%

• TAXOL--MECHANISMS OF ACTION AND RESISTANCE

  Band Horwitz, S., Smith, A., McDaid, H. M., Band Horwitz, S., McDaid, H. M., Band Horwitz, S., McDaid, H. M., McDaid, H. M., Rose, S. A., Rose, S. A., Rose, S. A., Rose, S. A., Rose, S. A. & Band Horwitz, S.

  6/1/98 → 6/30/21

  Project: Research project

  • paclitaxel 100%
  • microtubules 25%
  • tubulin 20%
  • mechanism of action 17%
  • drugs 13%

• Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm

  Band Horwitz, S., McDaid, H. M., Band Horwitz, S. & Smith, A.

  National Cancer Institute

  6/1/98 → 6/30/21

  Project: Research project

  • Discodermolide 100%
  • discodermolide 46%
  • Psychological Inhibition 39%
  • Cell Death 37%
  • Resistance 31%

• STABLE CAMPTOTHECIN FORMULATIONS FOR CANCER TREATMENT

  Perez-Soler, R.

  5/6/98 → 8/31/04

  Project: Research project

  • Camptothecin 100%
  • Lactones 24%
  • Drug Compounding 22%
  • Neoplasms 15%
  • Topoisomerase Inhibitors 14%

• HIV THERAPY ADHERENCE AND VIRAL RESISTANCE IN DRUG USERS

  Schoenbaum, E. & Arnsten, J. H.

  5/1/98 → 3/31/04

  Project: Research project

  • HIV 100%
  • Drug Users 82%
  • Viral Load 76%
  • Drug Resistance 60%
  • Cultural Characteristics 19%

• CURCUMIN--MECHANISMS OF CHEMOPREVENTION

  Augenlicht, L. H.

  5/1/98 → 2/28/02

  Project: Research project

  • Sulindac 100%
  • Curcumin 99%
  • Non-Steroidal Anti-Inflammatory Agents 31%
  • Clinical Studies 13%
  • Volatile Fatty Acids 12%

• CURCUMIN--MECHANISMS OF CHEMOPREVENTION

  Augenlicht, L. H.

  National Cancer Institute

  5/1/98 → 2/28/02

  Project: Research project

  • Sulindac 100%
  • Curcumin 90%
  • Chemoprevention 72%
  • Non-Steroidal Anti-Inflammatory Agents 31%
  • Clinical Studies 13%

• TOXOPLASMA DEVELOPMENT AND CELL CYCLE

  Kim, K.

  4/1/98 → 3/31/03

  Project: Research project

  • cell cycle 100%
  • bradyzoites 79%
  • Toxoplasma gondii 68%
  • Toxoplasma 60%
  • tachyzoites 50%

• Preservation &Replacement of Beta Cells in IDDM

  Fleischer, N.

  National Institute of Diabetes and Digestive and Kidney Diseases

  2/5/98 → 7/31/10

  Project: Research project

  • Type 1 Diabetes Mellitus 100%
  • HLA-A2 Antigen 57%
  • Ligands 20%
  • Peptides 18%
  • T-Lymphocytes 17%

• MARC PREDOCTORAL FELLOWSHIP

  Rivera, J.

  1/1/98 → 12/31/01

  Project: Research project

  • Immunology 100%
  • Organism 91%
  • Fellowship 91%
  • Vaccine 91%
  • Molecular Biology 89%

• DYSREGULATION OF GLUCOSE HOMEOSTATIS IN AGING

  Barzilai, N.

  9/30/97 → 8/31/00

  Project: Research project

  • abdominal fat 100%
  • insulin 61%
  • glucose 59%
  • liver 41%
  • metabolism 41%

• GENERAL CLINICAL RESEARCH CENTER M01 RR12248

  Purpura, D. & Spiegel, A. M.

  National Center for Research Resources

  9/30/97 → 5/31/08

  Project: Research project

  • director 100%
  • medicine 51%
  • children's hospital 33%
  • neurology 31%
  • epilepsy 29%

• RENAL PATHOGENICITY OF ANTIDNA ANTIBODIES

  Putterman, C.

  9/1/97 → 8/31/02

  Project: Research project

• DIAPHRAGM ADAPTATIONS TO CHRONIC RESISTIVE LOADING

  Prezant, D. J.

  8/1/97 → 6/30/02

  Project: Research project

  • Diaphragm 100%
  • Oxidative Phosphorylation 50%
  • Respiratory Muscles 43%
  • Fatigue 37%
  • Myosin Heavy Chains 31%

• DIAPHRAGM ADAPTATIONS TO CHRONIC RESISTIVE LOADING

  Prezant, D. J.

  National Heart, Lung, and Blood Institute

  8/1/97 → 6/30/02

  Project: Research project

  • Diaphragm 100%
  • Oxidative Phosphorylation 54%
  • Respiratory Muscles 47%
  • Fatigue 40%
  • Myosin Heavy Chains 34%

• LUNG CANCER SUSCEPTIBILITY MARKERS IN SURROGATE TISSUES

  Spivack, S. D.

  7/25/97 → 6/30/02

  Project: Research project

  • Lung Neoplasms 100%
  • Molecular Epidemiology 55%
  • Lung 42%
  • Biomarkers 41%
  • Molecular Biology 38%

• COLON CANCER--MOLECULAR BIOLOGY OF CELL RESPONSE TO DIET

  Augenlicht, L. H.

  7/15/97 → 6/30/02

  Project: Research project

  • apoptosis 100%
  • short chain fatty acids 97%
  • colorectal neoplasms 53%
  • metabolism 50%
  • genetic models 49%

• COLON CANCER--MOLECULAR BIOLOGY OF CELL RESPONSE TO DIET

  Augenlicht, L. H.

  National Cancer Institute

  7/15/97 → 6/30/02

  Project: Research project

  • colorectal neoplasms 100%
  • apoptosis 83%
  • short chain fatty acids 81%
  • molecular biology 76%
  • metabolism 42%

• MAPPING GENES LINKED TO AUTOIMMUNE THYROID DISEASES

  Tomer, Y.

  7/1/97 → 6/30/98

  Project: Research project

  • thyroid diseases 100%
  • iodide peroxidase 26%
  • thyroglobulin 24%
  • linkage (genetics) 24%
  • genes 12%

• CELL CYCLE REGULATION AND TOXOPLASMA DEVLOPMENT

  Kim, K.

  4/1/97 → 3/31/02

  Project: Research project

• Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI

  Sahoo, D., Williams, D. L. & Pessin, J. E.

  National Heart, Lung, and Blood Institute

  4/1/97 → 3/31/22

  Project: Research project

  • Apolipoprotein A-I 100%
  • HDL Lipoproteins 92%
  • Cholesterol 88%
  • CD36 Antigens 75%
  • Cholesterol Esters 56%

• CHOLESTEROL METABOLISM--ROLE OF APOA I

  Pessin, J. E., Rose, S. A., Rose, S. A. & Rose, S. A.

  4/1/97 → 3/31/21

  Project: Research project

  • Apolipoprotein A-I 100%
  • Cholesterol Esters 76%
  • Lipoproteins 71%
  • HDL cholesteryl ester 64%
  • Scavenger Receptors 48%

• ANTIBODY ACTION MECHANISM AGAINST CRYPTOCOCCUS NEOFORMAN

  Feldmesser, M.

  National Institutes of Health

  8/1/96 → 7/31/01

  Project: Research project

  • Cryptococcus neoformans 100%
  • Antibodies 43%
  • Lung 36%
  • Infections 21%
  • Fungi 20%

• DEVELOPMENT OF L NDDP FOR THE TREATMENT OF CISPLATIN-RES

  Perez-Soler, R.

  7/1/96 → 6/30/00

  Project: Research project

• INSULIN REGULATION OF RAS-DEPENDENT SIGNALING PATHWAYS

  Pessin, J. E.

  6/1/96 → 5/31/05

  Project: Research project

• COLON CELL DIFFERENTIATION--DCC ROLE IN MUC2 EXPRESSION

  Augenlicht, L. H.

  National Cancer Institute

  6/1/96 → 3/31/02

  Project: Research project

  • Mucins 100%
  • Cell Differentiation 67%
  • Colon 62%
  • Genes 37%
  • DCC Genes 28%

• COLON CELL DIFFERENTIATION--DCC ROLE IN MUC2 EXPRESSION

  Augenlicht, L. H.

  6/1/96 → 3/31/02

  Project: Research project

• IMMUNE MECHANISMS OF REACTIVATION OF TUBERCULOSIS

  Chan, J.

  4/1/96 → 3/31/01

  Project: Research project

• REGULATION OF GLUCOSE TRANSPORTER GENE EXPRESSION

  Pessin, J. E.

  9/1/95 → 8/31/99

  Project: Research project

  • diabetes 100%
  • glucose transporters 92%
  • insulin 81%
  • tissues 72%
  • genes 48%

• Mechanism of Renal Prostaglandin Transport

  Schuster, V. L.

  National Institute of Diabetes and Digestive and Kidney Diseases

  5/1/95 → 6/30/12

  Project: Research project

  • Prostaglandins 100%
  • Kidney 53%
  • prostaglandins 48%
  • kidneys 37%
  • anions 22%

• QUANTIFICATION OF GENETIC INSTABILITY IN COLON TUMORS

  Augenlicht, L. H.

  5/1/95 → 4/30/97

  Project: Research project

  • genetic instability 100%
  • neoplasms 55%
  • microsatellite repeats 53%
  • penetrance 39%
  • adjuvants 30%

• MECHANISMS OF RENAL PROSTAGLANDIN TRANSPORT

  Schuster, V. L., Schuster, V. L. & Rose, S. A.

  5/1/95 → 6/30/12

  Project: Research project

  • prostaglandins 100%
  • kidneys 89%
  • anions 47%
  • transporters 27%
  • thromboxanes 19%